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PAI-1 deficiency attenuates the fibrogenic response to ureteral molecular pathways that contribute to this process of
obstruction. renal destruction is a necessary first step toward the devel-
Background. Progressive renal disease is characterized by opment of new therapeutic interventions. Current evidencethe induction of plasminogen activator inhibitor-1 (PAI-1),
supports the view that fibrosis of several solid organs,suggesting that impaired activity of the renal plasmin cascade
may play a role in renal fibrosis. including the kidney, is a consequence of perturbation
Methods. To test this hypothesis, the severity of renal fibro- of the normal balance between extracellular matrix syn-
sis caused by unilateral ureteral obstruction (UUO) was com- thesis and its degradation. The reversible nature of ex-pared in PAI-1 wild-type (/) and PAI-1 deficient (/) mice.
perimental renal interstitial fibrosis at the early stagesThe extent of interstitial inflammation and fibrosis, renal plas-
minogen activator and plasmin activity, and renal expression of of the disease [3] and the striking decrease in renal colla-
profibrotic genes was evaluated after 3, 7, and 14 days of UUO. genolytic activity observed in severe renal fibrosis models
Results. Renal PAI-1 mRNA levels increased 8- to 16-fold [4] suggest a crucial role for impaired matrix degradationin the / mice after UUO surgery, and PAI-1 protein was
in renal fibrogenesis. The serine proteinase plasmin isdetected in kidney homogenates. Interstitial fibrosis was sig-
thought to play an important role, primarily throughnificantly attenuated in / mice compared with / mice at
day 7 and day 14, based on the interstitial area stained with activation of latent matrix metalloproteinases [5, 6]. Plas-
picrosirius red and total kidney collagen content. However, min itself also has limited matrix-degrading activity. The
neither the mean renal plasminogen activator nor plasmin ac-
active enzyme plasmin is liberated from its proenzymetivities were increased in / mice compared with / mice.
plasminogen by two types of plasminogen activatorsThe number of interstitial macrophages were significantly lower
in the / mice three and seven days after UUO; interstitial (PAs): urokinase type (uPA) and tissue type (tPA).
myofibroblasts were significantly fewer at three days. At the The generation of plasmin is highly regulated by the
same time points, this altered interstitial cellularity was associ-
PA inhibitors (PAIs). Among several known PAIs, PAI-1ated with a significant reduction in renal mRNA levels for trans-
is thought to be the major physiological inhibitor of bothforming growth factor- and procollagens 1(I) and 1(III).
Conclusions. These studies establish an important fibrogenic uPA and tPA [5–7]. Increased expression of PAI-1 has
role for PAI-1 in the renal fibrogenic response. The results been reported in several progressive renal diseases, in-
demonstrate that one important fibrosis-promoting function of
cluding obstructive uropathy, suggesting a significantPAI-1 is its role in the recruitment of fibrosis-inducing cells,
functional role for PAI-1 in the development of renalincluding myofibroblasts and macrophages.
fibrosis [8–14]. To evaluate this hypothesis, the severity
of renal interstitial fibrosis was compared between PAI-1–
deficient (/) mice and wild-type (/) mice in re-Despite great advances in medical technologies, the
sponse to unilateral ureteral obstruction (UUO) [15, 16].number of patients with end-stage renal disease receiving
Our findings demonstrate that PAI-1 is markedly in-dialytic therapy or a renal transplant continues to in-
crease, imposing enormous medical and socioeconomic duced by UUO, and genetic PAI-1 deficiency signifi-
burdens [1]. Renal interstitial fibrosis is a final common cantly attenuates renal interstitial fibrosis. However, nei-
pathway that leads to progressive renal failure irrespec- ther intrarenal PA activity nor plasmin activity were
tive of the initial cause of damage [2]. Elucidating the increased in / mice compared with / mice by
UUO. Instead, the dampened fibrogenic reaction was
characterized by a delayed interstitial inflammatory re-
Key words: interstitial fibrosis, plasminogen activator inhibitor-1, myo-
sponse and significantly decreased renal mRNA levelsfibroblast, macrophage, unilateral ureteral obstruction, renal fibro-
genesis. for genes encoding transforming growth factor- (TGF-)
and extracellular matrix proteins. 2001 by the International Society of Nephrology
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METHODS detected using the Enhanced Polymer One-Step Staining
(EPOS) reagent (Dako Corp.) as previously described [18].Experimental design
The experiments were performed on PAI-1 / and Total collagen assay
/ male mice with an identical genetic background Hydroxyproline concentrations in hydrolysates ex-
(87.5% C57BL6; 12.5% 129SV). Breeding pairs of mice tracted from accurately weighed frozen kidney samples
were obtained from Dr. P. Carmeliet (Leuven, Belgium) were chemically measured according to the technique of
[17]. The genotype was confirmed by Southern blot anal- Kivirikko, Laitinen, and Prockop [19]. Total collagen was
ysis of ear pinna DNA. Left kidney UUO or sham sur- assumed to contain 12.7% hydroxyproline by weight and
gery was performed under general anesthesia when the final results were expressed as g collagen/mg kidney
mice reached an average age of 12.5 weeks. Four groups weight.
of PAI-1/ and four groups of PAI-1/mice (N 3
Northern blot analysisto 6 per group) were studied: sham surgery, three-day
(3D) UUO, seven-day (7D) UUO, and 14-day (14D) Total kidney RNA was isolated using the TRIZOL sin-
UUO. To mark proliferating cells, 5-bromo-2-deoxyuri- gle-step reagent (GIBCO BRL Life Technologies, Grand
dine (BrdU; Sigma Chemical Co., Saint Louis, MO, USA) Island, NY, USA). RNA samples (20 g) from each
was injected intraperitoneally (50 g/g body weight) 24 individual animal were separated by electrophoresis
hours prior to the sacrifice. Animals were killed by exsan- through 1% agarose gels and transferred to nylon mem-
guination under general anesthesia with isoflurane. The branes (GeneScreen Plus; New England Nuclear Life
obstructed or sham-operated left kidney was immedi- Science Products, Boston, MA, USA). The membranes
ately decapsulated, weighed, and cut into several pieces were hybridized in QuickHyb hybridization solution
(Stratagene, La Jolla, CA, USA) containing [32P]dCTP-that were stored at 80C for subsequent studies, or
labeled cDNA probes. After washing, autoradiographsthey were fixed in 10% neutral-buffered formalin and
were obtained. The density of each band was quantifiedembedded in paraffin for histological analysis. All proce-
using the NIH Image program. The results were adjusteddures were performed in compliance with guidelines es-
for unequal RNA loading based on the intensity of thetablished by the National Research Council Guide for
ethidium bromide-stained 28s ribosomal bands. Resultsthe Care and Use of Laboratory Animals.
were expressed in arbitrary densitometric units standard-
Histological examination ized to a mean value of 1.0 unit for the sham / group
mice (or the 3D UUO group when the band density ofThe severity of interstitial fibrosis was evaluated histo-
sham mice was too faint to be measured).logically using polarized light microscopy to examine
The cDNA probes used were rat PAI-1 from Dr. T.paraffin-embedded sections stained with picrosirius red
Gelehrter (University of Michigan, Ann Arbor, MI, USA)that identifies interstitial collagen fibers. The tubulo-
[20], rat uPA from Dr. J. Degen (University of Cincin-interstitial area stained (expressed as % total area ex-
nati, Cincinnati, OH, USA), mouse tPA from Dr. S. Strick-cluding glomeruli and large vessels) was quantified in
land (State University of New York, Stony Brook, NY,five random, nonoverlapping cortical fields at	400 mag-
USA) [21], mouse 2 anti-plasmin from Dr. A. Sappinonification using a computer-assisted image analysis sys-
(University of Geneva, Geneva, Switzerland) [22], rattem (Optimas image analysis software; Optimas Corp.,
1(I) procollagen from Dr. S. Thorgeirsson (National Can-
Bothell, WA, USA).
cer Institute, Bethesda, MD, USA) [23], mouse 1(III)
Interstitial cellularity was characterized and quantified procollagen from Dr. B. deCrombrugghe (M.D. Anderson
after immunoperoxidase staining for macrophages (F4/80 Cancer Center, Houston, TX, USA) [24], and rat TGF-1
rat anti-mouse macrophage monoclonal antibody; Sero- from Dr. S. Qian (National Cancer Institute) [25].
tec Ltd., Oxford, UK), myofibroblasts (peroxidase-con-
jugated murine anti-human -smooth muscle actin 1A4 PAI-1 Western blotting
monoclonal antibody from Dako Corp., Carpinteria, CA, Kidney samples containing 20g of protein were sepa-
USA), and proliferating cells (MAS 250 rat anti-BrdU rated under reducing condition on 10% sodium dodecyl
monoclonal antibody from Harlan Sera-Lab Ltd., Lough- sulfate (SDS)-polyacrylamide gels and transferred onto
borough, UK). F4/80 and MAS 250 were detected with nitrocellulose membranes. Equal loading and transfer of
peroxidase-conjugated, mouse plasma-absorbed F(ab)2 the samples were confirmed by staining the blot with
goat anti-rat IgG (Accurate Chemical & Scientific Corp., 0.1% amido black in 30% methanol and 10% acetic acid
Westbury, NY, USA) using 3,3-diaminobenzidine (DAB) solution. Membranes were stained with sheep anti-mouse
as the chromogen (Dako Corp.) and methyl green coun- PAI-1 IgG (American Diagnostica Inc., Greenwich, CT,
terstaining. Sections stained with the secondary antibody USA) followed by peroxidase-conjugated rabbit anti-
sheep IgG (Accurate Chemical & Scientific Corp.). Per-alone were negative. Staining of the 1A4 antibody was
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Fig. 2. Total kidney collagen in () / and () / mice. Results
are mean 
 1 SD. *P  0.05 compared with sham controls of the same
genotype.
under liquid nitrogen frozen conditions using a prechilled
mortar and pestle. The powder was mixed with homoge-
nizing buffer (50 mmol/L Tris pH 7.6, 1% SDS) and centri-
fuged (14,000 	 g) for 10 minutes. The protein concen-
tration of the supernatant was measured using the Brad-
ford protein assay (Bio-Rad Laboratories, Hercules, CA,
USA), and aliquots were stored at 80C.
Plasminogen gel zymography. To detect renal PA ac-
tivity, kidney supernatants (1g protein) were separated
under nonreducing conditions on 10% SDS-polyacryl-
amide gels containing plasminogen (10 g/mL) and ca-
sein (2 mg/mL) according to the zymographic methods
of Roche, Campeau, and Shaw with a few modifications
[26]. After electrophoresis, the gel was washed with 2.5%
Triton X-100 and incubated in 0.1 mol/L glycine (pH 8.3)
for 15 hours at 37C. After the gels were stained with
Coomassie blue as described by Zehr, Savin, and Hall,
PA activity was revealed as clear lytic zones [27]. The
density of each lytic band was quantified using the NIH
Image program. Linearization of the assay was ensured
using serial dilutions of low molecular weight (33 kD)
human uPA (Calbiochem-Novabiochem Corp., La Jolla,
CA, USA) to generate a standard curve. In some assays,
1 mmol/L of amiloride was mixed into the Triton solution
and glycine buffer in order to distinguish uPA from tPA.Fig. 1. Sirius red staining of interstitial collagen fibrils. (A–D) These
are from plasminogen-activator inhibitor-1 (PAI-1) wild-type (/) Amiloride is known to inhibit uPA but not tPA [28]. To
mice that were sham-operated (sham), and after 3, 7 and 14 days (3D, distinguish the PA from metalloproteinases, the samples7D, and 14D) of unilateral ureteral obstruction (UUO), respectively.
were also run on gels without plasminogen.(E–H) These are / sham, 3D, 7D, and 14D UUO, respectively
(	400). (I) Data are mean 
 1 SD % of the interstitial area stained. Chromogenic assay of plasmin activity. Total kidney
Symbols are: ()  mice; () / mice; *P  0.05 compared with
plasmin activity was measured using a plasmin-specificsham controls of the same genotype.
chromogenic substrate, Chromozym PL (Boehringer
Mannheim, Indianapolis, IN, USA), as described by Ar-oxidase activity was detected using the enhanced chemi-
noletti et al [29]. This substance is specifically cleavedluminescence detection system (Amersham Pharmacia
by plasmin into a residual peptide and 4-nitraniline,Biotech Inc., Piscataway, NJ, USA).
which can be detected spectrophotometrically. Samples
Renal plasminogen activator and plasmin activity (100 L) containing 80 g of kidney protein, 750 L of
50 mmol/L Tris (pH 8.2), and 100 L of chromogenicSample preparation. Frozen kidneys pieces (25% of
the kidney) were individually ground into a fine powder substrate were mixed in a cuvette. The absorbance was
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Fig. 3. (A) Representative Northern blot auto-
radiograph of renal mRNA levels for plasmino-
gen-activator inhibitor-1 (PAI-1), tissue-type
plasminogen activator (tPA), urokinase-type
plasminogen activator (uPA), and 2-antiplas-
min (2-AP). The graph shows the results of
PAI-1 Northern blotting when RNA from each
experimental animal was loaded into separate
wells, expressed in arbitrary units as mean 

1 SD (B). No PAI-1 mRNA band was detected
in the kidneys of the / mice. *P  0.05
compared with sham controls of the same ge-
notype. Similar analyses (data not shown)
found a significant 50% increase in uPA only
at 7D after UUO and a 300 to 400% increase
in tPA at 3D, 7D, and 14D after UUO com-
pared with sham kidneys, and a significant 20
to 60% decrease in 2-AP at all time points.
There were no differences in the tPA, uPA,
and 2-AP responses between the / and
/ mice.
measured at 405 nm twice over a two-hour interval. The
increase in absorbance, corresponding to plasmin activ-
ity, was calculated. A standard linear curve was gener-
ated with serial dilutions of porcine plasmin (Sigma
Chemical Co.). Results were expressed in arbitrary delta
spectrophotometric units standardized to a mean value
of 1.0 U for sham-operated / mice.
Macrophage chemotaxis assay
Thioglycollate-elicited peritoneal macrophages from
five different mice were placed in individual lower wells
(35,000 per well) of a microchemotaxis chamber as de-
scribed by Falk, Goodwin, and Leonard [30]. Separated
from the lower wells by a polycarbonate 5 m pore filter
(Millipore, Bedford, MA, USA), chemotactic substances
were placed in triplicate in the upper wells. The chamber
was incubated at 37C for four hours in humidified air
Fig. 4. PAI-1 Western blotting of kidney supernatants identified a with 5% CO2. The filter was removed, methanol fixed,
definite PAI-1 protein band (53 kD) only in the / mice at 7D and and stained with Diff-Quick (Dade Diagnostics, Aguada,14D. Amido black staining shown in the lower portion of this figure
confirmed equivalency of protein loading and transfer. Puerto Rico). Numbers of macrophages in 10 random
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Fig. 6. Renal plasmin activity expressed as mean relative activity 

1 SD. Symbols are: ()  mice; () / mice; *P  0.05 compared
with sham controls of the same genotype.
gen levels at 7D; sufficient kidney tissue was not available
for D14 measurements (Fig. 2). By linear regression anal-
ysis, there was a strong positive correlation between the
tubulointerstitial area stained with picrosirius red and the
total kidney collagen content (r  0.80, P  0.000009).
Profile of the intrarenal PA/plasmin cascade
Fig. 5. (A) Representative plasminogen gel zymogram. The graph illus- Gene and protein expression. Northern blotting for
trates the mean relative activity after analysis of each experimental PAI-1 showed a single band at 3.2 kb in the PAI-1 /
animal (B). Symbols are: ()  mice; () / mice; *P  0.05
mice. The band was barely visible in sham-operated/compared with sham controls of the same genotype. Abbreviation is:
H.uPA, human urokinase-type plasminogen activator. mice but was strongly induced in response to UUO (Fig.
3). PAI-1 protein was detected by Western blotting of
kidney homogenates from UUO, but not sham mice (Fig.
4). PAI-1 mRNA and protein were undetectable in the
fields (	400) were counted. Added to the upper chamber kidneys of PAI-1 / mice at all time points.
were formyl-methionyl-leucyl-phenylalanine (f-met-leu- Renal uPA mRNA was abundantly expressed in the
phe, 108 mol/L; Sigma Chemical Co.) as the positive sham mice. Renal tPA mRNA was expressed at low
control and media alone (2% albumin HEPES-RPMI) levels in sham kidneys. Renal mRNA levels for both
as the negative control and serial dilutions (108 to 1013) plasminogen activators were increased after UUO sur-
of mouse recombinant uPA or PAI-1 (American Diag- gery mice, but to a similar degree in the / and /
nostica Inc.). mice (Fig. 3).
Since2 antiplasmin (2-AP) is the major plasmin inhib-Statistical analysis
itor expressed in normal kidneys (personal observations)
Results were expressed as mean 
 1 SD. Results were [22], its expression was examined and found to be signifi-
analyzed by the Mann Whitney U test. A P value 0.05 cantly decreased after UUO surgery (Fig. 3). The mean
was considered statistically significant. message levels at 3D and 7D UUO were higher in the
/ than the / mice, but the difference was not
statistically significant (P  0.12 at 3D, P  0.07 at 7D).RESULTS
Enzymatic activity. Plasminogen gel zymography pro-
Severity of renal fibrosis duced a major lytic band at 40 kD and a smaller band
The mean weight of the obstructed left kidneys (cor- at 28 kD (Fig. 5). This activity was identified as uPA
rected for body weight) from the / mice was signifi- based on its size and by the complete disappearance of
cantly lower than the / mice at 14D, suggesting more both bands when plasminogen was eliminated from the
severe fibrosis (3.9 
 0.6 vs. 5.0 
 0.3 	 103 mg/mg). gel or when the gel was treated with amiloride (data not
Histologically, the degree of interstitial fibrosis, quanti- shown). The 40 kD uPA activity increased significantly
fied as the percentage of tubulointerstitial area stained in UUO mice at 7D and 14D compared with sham mice;
by picrosirius red, was significantly less in the PAI-1/ there was no difference between / and / mice.
mice than in/ mice (Fig. 1). This attenuation in renal Similarly, intra-renal plasmin activity increased signifi-
cantly after UUO surgery. The only difference betweenfibrosis severity was also evident in the total kidney colla-
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Fig. 7. (A) Representative Northern blot autoradiograph of renal mRNA levels for 1(I) procollagen (Col I) and 1(III) procollagen (Col III)
and transforming growth factor- (TGF-). The graphs show the results when RNA from each experimental animal was loaded into separate
wells and probed, expressed in arbitrary units as mean 
 1 SD (B). Symbols are: ()  mice; () / mice; *P  0.05 compared with sham
controls of the same genotype.
/ and / mice was a paradoxically higher level in Interstitial cellularity
the / mice at 3D (Fig. 6). The number of interstitial macrophages and interstitial
myofibroblasts increased in response to UUO, but theRenal expression of profibrotic genes
intensity of the response was significantly attenuated inNorthern blotting was performed to evaluate the pos-
the / mice at 3D and 7D compared with the /sibility that genetic manipulations of PAI-1 might alter
mice (Figs. 8 and 9). Similar results were obtained whenthe expression of other genes currently thought to be
the number of F4/80-positive interstitial macrophagesinvolved in renal fibrosis. Renal mRNA levels for TGF-1,
was manually counted after indirect immunofluores-1(I) procollagen, and 1(III) procollagen increased in
cence staining using ethidium bromide to identify cellresponse to UUO and were significantly higher in /
mice than in / mice at 3D and 7D UUO (Fig. 7). nuclei as previously described (data not shown) [31].
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Fig. 8. F4/80 interstitial macrophages. (A–D)
These are / sham, 3D, 7D, and 14D UUO,
respectively. (E–H) These are / sham, 3D,
7D, and 14D UUO, respectively (	400). (I)
The graph is % interstitial area stained ex-
pressed as mean 
 1 SD. *P  0.05 compared
with sham controls of the same genotype.
Very few BrdU-positive tubulointerstitial cells were ob- sion. Furthermore, genetic deficiency of PAI-1 had a
protective effect, significantly attenuating the severity ofserved in sham kidneys. There was a striking 30- to 60-
fibrosis at least until 14 days. While the obstructed wild-fold increase in the number of BrdU-positive interstitial
type kidney is already severely damaged by 14 days, itcells 3, 7, and 14 days after UUO surgery in both geno-
is unknown whether redundant genetic pathways wouldtypes, suggesting that the difference in the number of
have compensated for PAI-1 deficiency after longer peri-interstitial macrophages and myofibroblasts between
ods of obstruction. Genetic manipulations of PAI-1 ac-/ mice and / mice was not due to different rates
tivity also have been shown to influence the severity ofof in situ proliferation (data not shown). There was a
pulmonary fibrosis [32].significant positive correlation between interstitial mac-
Additional studies, undertaken to determine the mech-rophages and renal TGF- mRNA levels (r  0.71,
anism underlying the protective effect of PAI-1 defi-P  0.000135) and between renal TGF- mRNA levels
ciency, yielded some unanticipated results. We were un-and interstitial myofibroblasts (r  0.65, P  0.000135).
able to show that the total renal uPA and plasmin
Macrophage chemotaxis for PAI-1 activities were decreased as a consequence of PAI-1 pro-
duction in the kidneys of the / mice. Normally, uPAA reproducible macrophage chemotactic response was
is synthesized in large quantities by renal tubules, andobserved to recombinant mouse PAI-1 at a concentra-
it is secreted into the urinary space. In the face of tubulartion of 1010 to 1011 mol/L (Fig. 10).
damage caused by obstruction, it is likely that this prote-
ase also leaks into the interstitial space. Within the inter-
DISCUSSION stitium, uPA may degrade some matrix proteins, but its
This study found that the development of interstitial major antifibrotic actions are thought to be a conse-
fibrosis in mice with complete ureteral obstruction was quence of its ability to generate plasmin, which activates
latent matrix-degrading proteases of the metalloprotein-associated with marked induction in renal PAI-1 expres-
Oda et al: PAI-1 deficiency attenuates renal fibrosis594
Fig. 9. -Smooth muscle actin (-SMA)-pos-
itive interstitial myofibroblasts. (A–D) These
are/ sham, 3D, 7D, and 14D UUO respec-
tively. (E–H) These are / sham, 3D, 7D,
and 14D UUO, respectively. (I) The graph is
% interstitial area stained expressed as
mean 
 1 SD. *P  0.05 compared with sham
controls of the same genotype (	400).
ase family. It is clear that the kidney is a rich source of
plasminogen activator activity, the level of which actually
increased rather than declined in response to ureteral
obstruction despite an 8- to 16-fold increase in the ex-
pression of its inhibitor PAI-1 in the / mice. This
may be due in part to the fact that 2-AP, the most
abundant known renal uPA inhibitor, was suppressed
following UUO. The assays used in this study measured
total kidney uPA and plasmin activity, and it is still
possible that there were significant localized differences
in the interstitial compartment that were not detected.
In addition, it is also conceivable that some of the uPA
and plasmin activity detected in these assays was due to
the activation of the proenzymes during the isolation
Fig. 10. Murine macrophage chemotactic response to murine PAI-1 and procedure. For these reasons, it is not possible to con-
uPA. Symbols are: () PAI-1; () uPA; (#) PAI-1 urokinase receptor clude with certainty that the protective mechanisms re-
macrophages (uPAR / Mφ) Results are the mean values of five
sulting from PAI-1 deficiency were independent of itsseparate experiments. The () control line indicates the mean number
of macrophages recruited in response to 108 mol/L f-met-leu-phe inhibitory effects on interstitial PA activity.
(42 
 7 in 5 experiments). The () control line indicates the mean The results of this study suggest a novel role for PAI-1number of macrophages recruited in response to media alone (18 
 6
in the recruitment of interstitial macrophages and myo-in 5 experiments). In three separate experiments using peritoneal Mφ
from mice with a genetic deficiency of the urokinase receptor fibroblasts, and that this activity is an important reason for
(uPAR/), a similar chemotactic response to PAI-1 was observed (# the blunted fibrogenic response observed in the PAI-1–linked with a broken line illustrate mean values). *P  0.05 compared
with the negative control. deficient mice. In support of this hypothesis is the obser-
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vation that the delayed appearance of interstitial macro- of directed motility at higher PAI-1 concentrations is a
phages and myofibroblasts was associated with lower typical feature of chemotactic molecules [41]. Similar
levels of expression of the genes encoding TGF-1 and results were obtained when peritoneal macrophages
interstitial collagens. Both interstitial macrophages and were isolated from mice with a genetic deficiency of the
myofibroblasts are a potential source of TGF- during uPA receptor, indicating that the chemotactic response
the active phase of renal fibrosis. In the present study, to PAI-1 is independent of this receptor. Whether this
there was a strong positive correlation between both of concentration of PAI-1 is within the physiologic range
these populations of interstitial cells and renal TGF- that might be encountered in diseased kidneys is cur-
mRNA levels, suggesting that the antifibrotic effects of rently unknown, but these findings suggest another plau-
the PAI-1–deficient state were closely linked with the sible explanation for the delayed interstitial influx of
delayed recruitment of TGF-–producing interstitial cells. monocytes after UUO in PAI-1–deficient mice. Presently,
Indeed, several other studies have suggested a role for it is not possible to dismiss the possibility that PAI-1 may
PAI-1 in cell migration, but its actions appear to be com- modulate interstitial macrophage recruitment indirectly
plex with both facilitatory and inhibitory effects reported. by regulating the generation of other chemotactic factors
PAI-1 may bind to vitronectin and block vitronectin- such as fibrin, monocyte chemoattractant protein-1, com-
integrin interactions, leading to the inhibition of cellular plement components C3a and C5a, RANTES, and/or
migration along extracellular matrices [33, 34]. However, osteopontin, for example. Ongoing studies are investigat-
other in vitro studies report that binding of PAI-1 to ing the effects of PAI-1 deficiency on the expression of
vitronectin actually interferes with vitronectin binding to these molecules in damaged kidneys.
the urokinase receptor and facilitates cell migration [35]. In summary, up-regulated expression of PAI-1 in re-
Additional evidence supporting a role for PAI-1 in the sponse to renal obstruction appears to play an important
promotion of cell migration comes largely from cancer role in the ensuing fibrogenic response. The results of
cell biology. For many human cancers, high tumor ex- the present study suggest that an important profibrotic
pression of PAI-1 is a poor prognostic indicator, pre- effect of PAI-1 is its ability to promote the recruitment
dictive of more aggressive local invasion and metastasis of fibrosis-inducing cells, including myofibroblasts and
[36]. In a recent study of transplanted malignant kera- macrophages.
tinocytes, genetic deficiency of PAI-1 prevented local
tumor invasion [37]. This beneficial effect was associated ACKNOWLEDGMENTS
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sion molecules. While some in situ proliferation of inter-
Abbreviations used in this article are: 2-AP, 2 antiplasmin; BrdU,stitial myofibroblasts and macrophages appears to occur
5-bromo-2-deoxyuridine; D, day post-obstruction; DAB, 3,3-diami-
[39, 40], the number of proliferating tubulointerstitial nobenzidine; PA, plasminogen activator; PAI-1, plasminogen-activator
inhibitor-1; TGF-, transforming growth factor-; tPA, tissue-typecells was not altered by the absence of PAI-1 in the
plasminogen activator; uPA, urokinase-type plasminogen activator;present study. It is possible that further studies will estab-
UUO, unilateral ureteral obstruction.lish a role for PAI-1 in the cascade of events that trans-
form the interstitial cellularity to a fibrosis-promoting
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